225 related articles for article (PubMed ID: 12923064)
1. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma.
Delgado M; Ganea D
FASEB J; 2003 Oct; 17(13):1922-4. PubMed ID: 12923064
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.
Delgado M; Ganea D
FASEB J; 2003 May; 17(8):944-6. PubMed ID: 12626429
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels.
Delgado M; Varela N; Gonzalez-Rey E
Glia; 2008 Aug; 56(10):1091-103. PubMed ID: 18442091
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
Delgado M; Jonakait GM; Ganea D
Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
[TBL] [Abstract][Full Text] [Related]
5. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.
Delgado M; Abad C; Martinez C; Juarranz MG; Arranz A; Gomariz RP; Leceta J
J Mol Med (Berl); 2002 Jan; 80(1):16-24. PubMed ID: 11862320
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia.
Zhao W; Xie W; Xiao Q; Beers DR; Appel SH
J Neurochem; 2006 Nov; 99(4):1176-87. PubMed ID: 17018025
[TBL] [Abstract][Full Text] [Related]
8. The brain as a target for inflammatory processes and neuroprotective strategies.
Skaper SD
Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
[TBL] [Abstract][Full Text] [Related]
9. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity.
Zheng LT; Ock J; Kwon BM; Suk K
Int Immunopharmacol; 2008 Mar; 8(3):484-94. PubMed ID: 18279803
[TBL] [Abstract][Full Text] [Related]
11. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
[TBL] [Abstract][Full Text] [Related]
12. The effects of vasoactive intestinal peptide in neurodegenerative disorders.
Deng G; Jin L
Neurol Res; 2017 Jan; 39(1):65-72. PubMed ID: 27786097
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
[TBL] [Abstract][Full Text] [Related]
14. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
[TBL] [Abstract][Full Text] [Related]
15. Chunghyuldan attenuates brain microglial inflammatory response.
Nam KN; Jung HJ; Kim MH; Kang C; Jung WS; Cho KH; Lee EH
Can J Physiol Pharmacol; 2009 Jun; 87(6):448-54. PubMed ID: 19526039
[TBL] [Abstract][Full Text] [Related]
16. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
Gonzalez-Rey E; Delgado M
Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells.
Gonzalez-Rey E; Delgado M
Brain Behav Immun; 2008 Jan; 22(1):35-41. PubMed ID: 17826030
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines.
Lai AY; Todd KG
Glia; 2006 Jun; 53(8):809-16. PubMed ID: 16541436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
